PERSPECTA

News from every angle

← Back to headlines

LifeVantage outlines FY 2027 capex amid CEO transition

Health supplement company LifeVantage projected $3M-$3.5M in capital expenditures for fiscal 2027 while withholding formal guidance during a leadership transition.

28 Aug, 00:00 — 28 Aug, 00:00
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed19h ago

LifeVantage outlines FY 2027 capex at $3M-$3.5M while withholding formal guidance amid CEO transition

Read full article →

Related Stories

Warsh Warns of Additional Rate Hikes at Jackson Hole Amid Persistent Inflation

45m ago

US-Mexico Trade Talks Stalled Over Dispute on Cheese Names

1h ago

White House Approves Plan to End H-1B 60-Day Grace Period

1h ago

Marvell, PayPal Lead Market Movers on Friday

1h ago